Toxic Potential of Ethanolic Extract of Acacia nilotica (Garad) in rats

Authors

  • Tarig M. El-Hadiyah Faculty of Pharmacy, The National Rebat University, Khartoum, Sudan
  • Nasruddin H. Abdulhadi Faculty of Pharmacy, The National Rebat University, Khartoum, Sudan
  • Eisha E. M. Badico School of Pharmacy, Ahfad University for Women
  • Egbal Y.G. Mohammed School of Pharmacy, Ahfad University for Women

DOI:

https://doi.org/10.52981/sjms.v6i1.1344

Keywords:

LD50, hepatotoxicity, nephrotoxicity

Abstract

Objective: The study aimed to investigate acute and sub-acute toxic potential of ethanolic extract
of Acacia nilotica (Garad) in rats.
Methods: LD50 of Garad was determined. Changes in behavioral response, induced by sub-acute
treatments were recorded. Elevated urea, creatinine, ALT (GPT) and AST (GOT) in plasma were
taken as evidence for impaired kidney and liver function.
Results: LD50 of Garad extract was found to be 215.36 mg/kg (124.84 – 317.47). Regarding sub
acute treatment, observations on seventh and fourteenth days showed slight to moderate sedation at
various doses. On day 21 no behavioral changes were recorded. However, a treatment for three
weeks induced significant elevation in urea and ALT (p < 0.05).
Conclusion: It can be concluded that the ethanolic extract of Garad has got some toxicity when
administered sub acutely and intraperitoneally in rats, particularly at high dose (60 mg/kg).

References

Al-Mustafa ZH and Dafallah AA. A study on the toxicology of Acacia nilotica. American Journal of Chinese Medicine. Saudi Arabia. 2000; 28(1):123-129.

Meena PD, Kaushik P, Shukla S et al. Anticancer and Antimutagenic Properties of Acacia nilotica (Linn.) on 7,12-dimethylbenz(a)anthracene-induced Skin Papillomagenesis in Swiss albino mice. Asian Pac J Cancer Prev. 2006; 7(4):627-632.

Chaubal R, Mujumdar AM, Puranik VG et al. Isolation and X-ray study of an anti-inflammatory active androstene steroid from Acacia nilotica. Arzneimittelforschung. 2006; 56(6):394-398.

Kaur K, Michael H, Arora S et al. In vitro bioactivity-guided fractionation and characterization of polyphenolic inhibitory fractions from Acacia nilotica (L.) Willd. ex Del. J Ethnopharmacol. 2005; 99(3): 353-360.

Ghosh MN. Statistical analysis. In: Fundamentals of experimental pharmacology. 2nd edition. Scientific book agency, Calcutta. 1984; pp. 177 - 190

Gilani AH, Shaheen F, Zaman M et al. Studies on antihypertensive and antispasmodic activities of methanol extract of Acacia nilotica pods. Phytother Res. 1999; 13(8):665-669.

Mosberg A T and Hayes A W. Subchronic toxicity testing. In: Principles and methods of toxicology. Editors: A. Wallace Hayes, Raven, second edition. New York. 1989; pp. 221 – 236

Turner RA. The organization of screening. In: Screening Methods in Pharmacology. Academic press, New York and London. 1965; pp. 22-41.

Mansour M. Protective effect of thymoquinone and desferrioxamine against carbon tetrachloride induced hepatotoxicity in normal mice. Life Sci. 2000; 66: 2583 – 2591.

Al-Majed AA, Mostafa AM, Al-Rikabi AC et al. Protective effects of oral arabic gum administration on gentamicin-induced nephrotoxicity in rats. Pharmacol Res. 2002; 46 (5):445-451.

Litchfield JT and Wilcoxon F. A simplified method for evaluating dose – effect experiments. J. Pharmacol. Exp. Ther. 1949; 96: 99 – 113.

Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol. 1983; 32:1441–1448.

Gabor M. Szent-gyorgyi and the bioflavonoids. In: Cody C, Middleton E Jr, Harnborne JB, Beretz A (Eds.), Progress in clinical and biological research. Vol. 280. New York, Alan R. Liss. 1988; pp. 1–15.

Pierpoint WS. Flavonoids in the human diet. In: Middleton CE, Jr, Harborne JB (Eds.), Progress in clinical and biological research. Vol. 213. New York, Alan R. Liss. 1986; pp. 125–140.

el Bahri L, Souilem O, Djegham M et al. Toxicity and adverse reactions to some drugs in dromedary (Camelus dromedarius). Vet Hum Toxicol. 1999; 41(1):35-38.

Mittler R, Merquiol E, Hallak-Herr E et al. Living under a "dormant" canopy: a molecular acclimation mechanism of the desert plant Retama raetam. Plant J. 2001; 25(4):407-416.

Maghrani M, Michel JB, Eddouks M. Hypoglycaemic activity of Retama raetam in rats. Phytother. Res. 2005; 19(2): 125 –128.

Maghrani M, Lemhadri A, Jouad H et al. Effect of the desert plant Retama raetam on glycaemia in normal and streptozotocin-induced diabetic rats. J Ethnopharmacol. 2003; 87(1):21-25.

Conforti F, Statti G, Tundis R et al. Antioxidant and cytotoxic activities of Retama raetam subsp. Gussonei. Phytother Res.2004; 18(7):585-587

Klaassen C and Doull J. Evaluation of safety: Toxicologic evaluation. In: Toxicology, the basic science of poisons. Editors: Klaassen C, Doull J and Amdur MO, Macmillan publishing co. inc. 1980; pp. 11-27.

Saad B, Dakwar S, Said O. et al. Evaluation of medicinal plant hepatotoxicity in co-cultures of hepatocytes and monocytes. eCAM. 2006; 3(1): 93-98.

Downloads

Published

2021-08-24

Issue

Section

Original Articles